KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $635.4 million.

  • West Pharmaceutical Services' Total Current Liabilities rose 2302.03% to $635.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $635.4 million, marking a year-over-year increase of 2302.03%. This contributed to the annual value of $550.4 million for FY2024, which is 1807.09% down from last year.
  • Latest data reveals that West Pharmaceutical Services reported Total Current Liabilities of $635.4 million as of Q3 2025, which was up 2302.03% from $604.6 million recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Total Current Liabilities registered a high of $671.8 million during Q4 2023, and its lowest value of $456.7 million during Q3 2022.
  • In the last 5 years, West Pharmaceutical Services' Total Current Liabilities had a median value of $550.4 million in 2024 and averaged $558.0 million.
  • As far as peak fluctuations go, West Pharmaceutical Services' Total Current Liabilities soared by 4018.58% in 2021, and later plummeted by 1876.93% in 2025.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Total Current Liabilities stood at $594.1 million in 2021, then fell by 12.64% to $519.0 million in 2022, then increased by 29.44% to $671.8 million in 2023, then fell by 18.07% to $550.4 million in 2024, then grew by 15.44% to $635.4 million in 2025.
  • Its Total Current Liabilities was $635.4 million in Q3 2025, compared to $604.6 million in Q2 2025 and $526.7 million in Q1 2025.